Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Área temáticas
Bioquímica(2)
Cultura e instituciones(2)
Dirección general(1)
Farmacología y terapéutica(1)
Fisiología humana(1)
Origen
scopus(4)
CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards
ArticleAbstract: Earlier we had found that the CYP2C9*2 allelic frequency was lower in Mexican-Americans living in CaPalabras claves:CYP2C9, Hispanics, Mexican-Americans, Mexican-Mestizos, Mexican-Tepehuanos, pharmacogeneticsAutores:Adrián LLerena, Alanis-Bãuelos R.E., Dorado P., Lares-Asseff I., Licinio J., Penãs-Lledó E.M., Sosa-Macías M.G., Wong M.L.Fuentes:scopusInfluence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico
ArticleAbstract: We previously documented the lowest frequency of CYP2C9*2 in Mexican indigenous Tepehuanos followedPalabras claves:ancestral components, CYP2C9, Mexican indigenous, pharmacogeneticsAutores:Adrián LLerena, Dorado P., Galaviz-Hernandez C., Lazalde-Ramos B.P., Licinio J., Martínez-Fierro M.L., Martínez-Sevilla V.M., Rangel-Villalobos H., Salazar-Flores J., Sosa-Macías M.G., Wong M.L.Fuentes:scopusLower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards
ArticleAbstract: Interethnic differences in cytochrome P450 polymorphism might be responsible, at least in part, forPalabras claves:CYP2C9, Hispanics, Mexican-Americans, pharmacogenetics, SpaniardsAutores:Adrián LLerena, Dorado P., Jepson R., Licinio J., O'Kirwan F., Wong M.L.Fuentes:scopusPharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools Deans of Education
ArticleAbstract: Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decadePalabras claves:Adverse drug reactions (ADRs), Continuing medical education, Cytochrome P450 enzymes, Education, International Society of Pharmacogenetics (ISP), personalized medicine, pharmacogenetics, Thiopurine methyltransferase (TPMT)Autores:Adrián LLerena, Dedoussis G., Flordellis C.S., Fuhr U., Gurwitz D., Kirchheiner J., Licinio J., Lunshof J.E., Manolopoulos V.G., Sheffield L.J., Siest G., Torricelli F., Vasiliou V., Wong S.Fuentes:scopus